Based on current research and public records, the "2022-206" identifier most frequently refers to the following high-profile academic and regulatory documents:
: Numerous 2022/2023 studies available on platforms like PubMed Central (PMC) investigate Retinoic Acid Receptors (RAR) —specifically 2022-206.rar
—and their role in treating conditions ranging from Hepatitis B to pulmonary fibrosis. Based on current research and public records, the